An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 5, 1997, Pages 1107-1113

  Murata, Rumi ^a   Nishimura, Yasumasa ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Angiogenesis inhibitor; C3H mammary carcinoma; Radiation; Reoxygenation; Tumor control dose assay

Indexed keywords

FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; CANCER CONTROL; CANCER RADIOTHERAPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; REOXYGENATION; TUMOR BLOOD FLOW;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; CYCLOHEXANES; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOVASCULARIZATION, PATHOLOGIC; SESQUITERPENES;

EID: 0030971274     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00628-1     Document Type: Article

References (40)

1. Baumann, M.; Liertz, C.; Baisch, H.; Wiegel, T.; Lorenzen, J.; Arps, H. Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice. Radiother. Oncol. 32:137-143; 1994.
2. Begg, A. C.; Hofland, I.; Van Glabbeke, M.; Bartelink, H.; Horiot, J. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC Cooperative Trial 22851. Semin. Radiat. Oncol. 2:22-25; 1992.
3. Brem, H.; Folkman, J. Analysis of experimental antiangiogenic therapy. J. Pediatr. Surg. 28:445-451; 1993.
4. Brem, H.; Gresser, I.; Grosfeld, J.; Folkman, J. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J. Pediatr. Surg. 28:1253-1257; 1993.
5. Brem, H.; Ingber, D.; Blood, C. H.; Bradley, D.; Urioste, S.; Folkman, J. Suppression of tumor metastasis by angiogenesis inhibition. Surg. Forum 42:439-441; 1991.
6. Folkman, J. Tumor angiogenesis. Adv. Cancer Res. 43:175-203; 1985.
7. Folkman, J. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285:1182-1186; 1971.
8. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82:4-6; 1990.
9. Grau, C.; Overgaard, J. The influence of radiation dose on the magnitude and kinetics of reoxygenation in a C3H mammary carcinoma. Radiat. Res. 122:309-315; 1990.
10. Hilmas, D. E.; Gillette, E. L. Microvasculature of C3H/Bi mouse mammary tumors after X-irradiation. Radiat. Res. 61:128-143; 1975.
11. Hilmas, D. E.; Gillette, E. L. Tumor microvasculature following fractionated X irradiation. Radiology 116:165-169; 1975.
12. Hirst, D. G. Oxygen delivery to tumors. Int. J. Radiat. Oncol. Biol. Phys. 12:1271-1277; 1986.
13. Ingber, D.; Fujita, T.; Kishimoto, S.; Sudo, K.; Kanamaru, T.; Brem, H.; Folkman, J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555-557; 1990.
14. Kallman, R. F.; DeNardo, G. L.; Stasch, M. J. Blood flow in irradiated mouse sarcoma as determined by the clearance of Xenon-133. Cancer Res. 32:483-490; 1972.
15. Kitakabu, Y.; Shibamoto, Y.; Sasai, K.; Ono, K.; Abe, M. Variations of the hypoxic fraction in the SCCVII tumors after single dose and during fractionated radiation therapy: Assessment without anesthesia or physical restraint of mice. Int. J. Radiat. Oncol. Biol. Phys. 20:709-714; 1991.
16. Kusaka, M.; Sudo, K.; Fujita, T.; Marui, S.; Itoh, F.; Ingber, D.; Folkman, J. Potent antiangiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun. 174:1070-1076; 1991.
17. Kusaka, M.; Sudo, K.; Matsutani, E.; Kozai, Y.; Marui, S.; Fujita, T.; Ingber, D.; Folkman, J. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br. J. Cancer 69:212-216; 1994.
18. Moulder, J. E.; Rockwell, S. Hypoxic fraction of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys. 10:695-712; 1984.
19. Murata, R.; Shibamoto, Y.; Sasai, K.; Oya, N.; Shibata, T.; Takagi, T.; Abe, M. Reoxygenation after single irradiation in rodent tumors of different types and sizes. Int. J. Radiat. Oncol. Biol. Phys. 34:859-865; 1996.
20. Nishimura, Y.; Ono, K.; Tsutsui, K.; Oya, N.; Okajima, K.; Hiraoka, M.; Abe, M. Esophageal cancer treated with radiotherapy: Impact of total treatment time and fractionation. Int. J. Radiat. Oncol. Biol. Phys. 30:1099-1105; 1994.
21. Nishimura, Y.; Murata, R.; Hiraoka, M. Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia. Br. J. Cancer 73:270-274; 1996.
22. Nishimura, Y.; Urano, M. The effect of hyperthermia on reoxygenation during the fractionated radiotherapy of two murine tumors, FSa-II and MCa. Int. J. Radiat. Oncol. Biol. Phys. 29:141-148; 1994.
23. Ritter, M. A. Cell proliferation. In: Mauch, P. M.; Loeffler, J. S., eds. Radiation oncology: Technology and biology. Philadelphia, PA: W. B. Saunders; 1994:538-539.
24. Sarkaria, J. N.; Fowler, J. F.; Lindstrom, M. J.; Jordan, V. C.; Mulcahy, R. T. The decreased influence of overall treatment time on the response of human breast tumor xenografts following prolongation of the potential doubling time (Tpot). Int. J. Radiat. Oncol. Biol. Phys. 31:833-840; 1995.
25. Shweiki, D.; Itin, A.; Soffer, D.; Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845; 1992.
26. Shweiki, D.; Neeman, M.; Itin, A.; Keshet, E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis, Proc. Natl. Acad. Sci. USA 92:768-772; 1995.
27. Suit, H. D.; Shalek, R. J.; and Wette, R. Radiation response of a C3H mammary carcinoma evaluated in terms of cellular radiation sensitivity. In: Cellular radiation biology. Baltimore, MD: Williams and Wilkins; 1965:514-530.
28. Teicher, B. A.; Depuis, N. P.; Kusumoto, T.; Robinson, M. F.; Liu, F.; Menon, K.; Coleman, C. N. Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy. Radiat. Oncol. Invest. 2:269-276; 1995.
29. Teicher, B. A.; Holden, S. A.; Ara, G.; Depuis, N. P.; Liu, F.; Yuan, J.; Ikebe, M.; Kakeji, Y. Influence of an anti-angiogenic treatment on 9L gliosarcoma: Oxygenation and response to cytotoxic therapy. Int. J. Cancer 61:732-737; 1995.
30. Teicher, B. A.; Holden, S. A.; Ara, G.; Sotomayor, E. A.; Huang, Z. D.; Chen, Y. N.; Brem, H. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other antiangiogenic agents. Int. J. Cancer 57:920-925; 1994.
31. Teicher, B. A.; Holden, S. A.; Depuis, N. P.; Kakeji, Y.; Ikebe, M.; Emi, Y.; Goff, D. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma. Breast Cancer Res. Treat. 36:227-236; 1995.
32. Toi, M.; Yamaoka, Y.; Imazawa, T.; Takayanagi, T.; Akutsu, K.; Tominaga, T. Antitumor effect of the angiogenesis inhibitor AGM-1470 and its combination effect with tamoxifen in DMBA induced mammary tumors in rats. Int. J. Oncol. 3:525-528; 1993.
33. Urano, M.; Fukuda, N.; Ando, K.; Koike, S.; Tanaka, N. Tumor control and regrowth probability after a single radiation of experimental animal tumors. J. Natl. Cancer Inst. 53:517-525; 1974.
34. Urano, M.; Nesumi, N.; Ando, K.; Koike, S.; Ohnuma, N. Repair of potentially lethal damage in acute and chronically hypoxic tumor cells in vivo. Radiology 118:447-451; 1976.
35. Urano, M.; Nishimura, Y.; Yaes, R. The relative significance of repopulation and hypoxic clonogens in the fractionated radiotherapy of a mouse tumor. Radiat. Res. 142:204-211; 1995.
36. Withers, H. R.; Taylor, J. M. G.; Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.
37. Yamamoto, T.; Sudo, K.; Fujita, T. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res. 14:1-4; 1994.
38. Yamaoka, M.; Yamamoto, T.; Ikeyama, S.; Sudo, K.; Fujita, T. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostatic carcinoma cell lines. Cancer Res. 53:5233-5236; 1993.
39. Yamaoka, M.; Yamamoto, T.; Masaki, T.; Ikeyama, S.; Sudo, K.; Fujita, T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chlo-roacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470). Cancer Res. 53:4262-4267; 1993.
40. Yanase, T.; Tamura, M.; Fujita, K.; Kodama, S.; Tanaka, K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res. 53:2566-2570; 1993.